A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Sponsor
Mati Therapeutics Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT01481051
Collaborator
(none)
57
6
10
9.5
0.9
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the efficacy, safety and duration of the L-PPDS (latanoprost punctal plug delivery system) at different dose levels.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 2 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
57 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
PPL GLAU 12: A Phase 2 Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)
Study Start Date
:
Nov 1, 2011
Actual Primary Completion Date
:
Sep 1, 2012
Actual Study Completion Date
:
Sep 1, 2012
Outcome Measures
Primary Outcome Measures
- IOP change from baseline [12 weeks to baseline]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Male or female at least 18 years old
-
Diagnosis of bilateral open angle glaucoma or ocular hypertension
-
Unmedicated IOP must be ≥22mm Hg
Exclusion Criteria:
-
Any significant vision loss in the last year
-
No contact lens use for the length of the study
-
Abnormal eye lids, eye infection, or diseases to the eye
-
Recent eye surgery
-
Uncontrolled medication conditions
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Sall Research Medical Center, Inc | Artesia | California | United States | 90701 |
2 | Wolstan & Goldberg Eye Associates | Los Angeles | California | United States | 90505 |
3 | West Coast Eye Care Associates | San Diego | California | United States | 92115 |
4 | Coastal Research Associates, LLC | Roswell | Georgia | United States | 30076 |
5 | R and R Eye Associates | San Antonio | Texas | United States | 78229 |
6 | Rocky Mountain Eye Care Associates | Salt Lake City | Utah | United States | 84107 |
Sponsors and Collaborators
- Mati Therapeutics Inc.
Investigators
- Study Director: Suzanne Cadden, QLT Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Mati Therapeutics Inc.
ClinicalTrials.gov Identifier:
NCT01481051
Other Study ID Numbers:
- PPL GLAU 12
First Posted:
Nov 29, 2011
Last Update Posted:
Sep 26, 2013
Last Verified:
Sep 1, 2013
Additional relevant MeSH terms: